AKT inhibitor

AKT is a protein central to the regulation of cell growth and division. Certain genetic mutations in breast cancer cells can lead to an overactivity of AKT proteins that cause tumors to grow. An AKT inhibitor is a drug that prevents this overactivity. Several are being researched, but currently only one, capivasertib (Truqap™), has been approved by the FDA.